Professional Medical Judgment and Pharmaceutical Marketing: Drawing Legal and Ethical Lines Around Conflict of Interest

Salbu, Steven R.

Journal: William & Mary Business Law Review

Volume: 12

First Page: 23

Year: 2021

Bluebook Citation: 12 WM. & MARY BUS. L. REV. 23 (2021)

Author: Steven R. Salbu: all 19 publications


Abstract

Pharmaceutical manufacturers develop relationships with healthcare providers for several purposes, including the marketing and sale of their products. Professional associations give guidance to physicians and companies for managing these relationships ethically. Some practices permitted by these associations entail conflicts of interest. This Article explores two of these practices: (i) company funding of external educational seminars, conferences, and continuing medical education; and (ii) company-hosted speaker programs.

The conflict of interest concerns raised by the former practice are manageable, and the practice should continue to be permitted subject to appropriate safeguards; however, the conflict of interest concerns raised by the latter practice create an unacceptable ethical hazard that cannot be managed. Company-hosted speaker programs should be prohibited.

Chat with this journal article using AI

Ask CiteLaw's AI Navigator anything about this journal article, verify citations, and research related authorities. Sign up for CiteLaw free today to get started.